BioStem Technologies, Inc. (BSEM)
3.43
-0.14
(-3.79%)
USD |
OTCM |
Jun 10, 16:00
BioStem Technologies Profit Margin (Quarterly) : -143.7% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -143.7% |
| December 31, 2025 | -111.7% |
| September 30, 2025 | 7.27% |
| June 30, 2025 | -1.14% |
| March 31, 2025 | 6.18% |
| December 31, 2024 | 64.78% |
| September 30, 2024 | 37.04% |
| June 30, 2024 | 8.44% |
| March 31, 2024 | 7.77% |
| December 31, 2023 | -23.96% |
| September 30, 2023 | -43.95% |
| June 30, 2023 | -267.2% |
| March 31, 2023 | -621.4% |
| December 31, 2022 | -475.4% |
| September 30, 2022 | -77.48% |
| June 30, 2022 | 15.01% |
| March 31, 2022 | -99.59% |
| December 31, 2021 | -23.54% |
| September 30, 2021 | -38.23% |
| June 30, 2021 | -40.13% |
| Date | Value |
|---|---|
| March 31, 2021 | -14.68% |
| December 31, 2020 | -57.08% |
| September 30, 2020 | -155.0% |
| June 30, 2020 | -293.0% |
| March 31, 2020 | -50.19% |
| June 30, 2019 | -296.1% |
| March 31, 2019 | -450.4% |
| December 31, 2018 | -701.9% |
| September 30, 2018 | -457.8% |
| June 30, 2018 | -2.47K% |
| March 31, 2018 | -2.10K% |
| December 31, 2017 | -656.8% |
| September 30, 2017 | -2.88K% |
| June 30, 2017 | -1.92K% |
| March 31, 2017 | -231.7% |
| December 31, 2016 | -523.7% |
| September 30, 2016 | -1.02K% |
| June 30, 2016 | -1.02K% |
| March 31, 2016 | -333.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -- |
| CorMedix, Inc. | 30.29% |
| Eloxx Pharmaceuticals, Inc. | -- |
| Cannabis Global, Inc. | -- |
| Axsome Therapeutics, Inc. | -33.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -45.89% |
| Return on Assets | -23.14% |
| Return on Invested Capital | -42.39% |
| Gross Profit Margin (Quarterly) | 52.47% |
| Operating Margin (Quarterly) | -144.8% |
| Return on Net Operating Assets | -34.75% |